GANX
Gain Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.69 / 10
Netural
Analyst sentiment is overwhelmingly bullish with a unanimous 'Strong Buy' rating from HC Wainwright & Co., yet historical win-rate is low at 20%. Fund-flow metrics are more encouraging with a 7.59/10 score, but overall and block trends are negative; only the Small-flow trend is positive, suggesting short-term speculative interest without sustained institutional support.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-19
InstitutionHC Wainwright & Co.
Times predicted5
Historical Win Rate20.0%
What is the market sentiment for GANX?
- GANX holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.69/10 (Netural).
